Medigen Biotechnology Corp 2023 Annual Report with Sustainability Disclosures
Company: Medigen Biotechnology Corp
Sector: Manufacturing
Country: Taiwan
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 403
The report presents the group's 2023 consolidated revenue of NT$1,157,720 thousand and describes continued development across biotechnology, vaccines, diagnostics, generic drugs, and cell therapy. It reports approximately 458.59 metric tons of 2023 CO2 emissions, along with water consumption and waste quantities. The company also states that it had not yet prepared a standalone sustainability report and was progressively implementing sustainable-development practices.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.